e-learning
resources
Milan 2017
Sunday, 10.09.2017
Markers of COPD progression
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of global cardiovascular risk on health related quality of life in patients with Chronic Obstructive Pulmonary Disease. Differences between frequent and infrequent exacerbator phenotype.
P. Gutierrez Castano (Malaga, Spain)
Source:
International Congress 2017 – Markers of COPD progression
Session:
Markers of COPD progression
Session type:
Thematic Poster
Number:
1089
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Gutierrez Castano (Malaga, Spain). Influence of global cardiovascular risk on health related quality of life in patients with Chronic Obstructive Pulmonary Disease. Differences between frequent and infrequent exacerbator phenotype.. 1089
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Impact of concomitant cardiovascular diseases on functional status and quality of life of patients with Chronic Obstructive Pulmonary Diseases
Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation
Year: 2019
Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003
Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020
Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
The Alonnisos Study: Correlation of Chronic Obstructive Pulmonary Disease risk with demographic, habitual and dietary factors in the general population of Alonnisos island
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
The population risk attribution associated with chronic airway obstruction from the results of the Canadian Obstructive Lung Disease study.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021
Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
A weighted genetic risk score based on 279 signals of association with lung function predicts Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Year: 2018
Fatigue and decreased health can predict mortality in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Impact on patients' health status following early identification of a COPD exacerbation
Source: Eur Respir J 2007; 30: 907-913
Year: 2007
One-year change in health status and outcomes in chronic obstructive pulmonary disease
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014
Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016
Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Health status measured with the CRQ does not predict mortality in COPD
Source: Eur Respir J 2002; 20: 1147-1151
Year: 2002
Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept